Skip to main content

Brian M. Connelly

Of Counsel 

Brian’s knowledge and experience bridges the gap between business and law.

After graduating from the George Washington University School of Law, he studied finance and accounting at the London School of Economics. His diverse background makes him a valuable partner for the firm and our clients. Brian spent 10 years at Faber before co-founding IncreVet, Inc., but he maintains his deep connection with the firm and clients within the biopharmaceutical industry who are forming companies, seeking financing, acquiring or disposing of assets, and creating supply and distribution arrangements.

In addition, Brian frequently counsels clients on their real estate activities, including leases for specialized laboratory space. He has drafted and negotiated office space and laboratory leases in major life sciences markets across the United States, including Greater Boston/Cambridge, Philadelphia, Raleigh, and Seattle.

More about Brian

  • Clerked for the Honorable Clyde Hamilton of the United States Court of Appeals for the Fourth Circuit
  • Served as legal counsel to the U.S. Senate's Committee on Governmental Affairs
  • Served as legal counsel to the Committee on Education and the Workforce in the U.S. House of Representatives
  • Private practice at a large law firm where he focused on representing technology, life sciences, and software companies
  • IDEXX Laboratories, Inc. where he was both an Associate General Counsel in the company’s legal department and a Senior Manager for Business Development helping IDEXX grow its reference laboratory network through acquisitions both inside and outside the United States

  • Sale of Bio-Pharm, Inc. to Torrent Pharmaceuticals
  • Merger of Motif Micro, Inc. to YPB Group Limited
  • Sale of AesRx (with a Phase II sickle cell program) to Baxter International
  • Alnylam Pharmaceuticals acquisition of Sirna Therapeutics from Merck for $175 million plus milestones and royalties
  • Spin-out of Florida Biologix business from University of Florida, and equity financing
  • Strategic investment from IMS Health in CliniWorks
  • Spin-out and equity financing of Mellitus from Harvard Medical School
  • Acquisition of PharmPro division of FluidAir by Mutual Pharmaceutical Company
  • Business combination of BioSTAR West and Hawaii Chitopure to form Synedgen
  • Long-Term Manufacturing and Supply Agreement between Bio- Pharm, Inc. and G&W Laboratories, Inc.
  • Acquisition of all of the shares of Porogen Corporation by Air Liquide Advanced Technologies U.S. LLC (pending)
  • Acquisition of all of the shares of Vgo Communications, Inc. by Vecna Technologies, Inc.
  • Sale of a controlling interest in HighRes Biosolutions, Inc. to NewtrAx

Leasing Work

  • Lease of approximately 66,000 RSF in Watertown, MA between Kala Pharmaceuticals, Inc. and 480 Arsenal Group, LLC
  • Lease of approximately 38,000 RSF in Cambridge, MA between Unum Therapeutics, Inc. and King Street Properties
  • Lease of approximately 15,000 RSF HQ office and Warehouse space in Nassau, NY between Level Solar, Inc. and Steel 327 New South Road LLC
  • Lease of approximately 48,500 RSF of space in Cambridge, MA between Alnylam, Inc. and RREEF America REIT II CORP
  • Lease of approximately 4,800 RSF of office space in Seattle, WA between Atara Biotherapeutics, Inc. and BPG Rock Westlake, LLC
  • Lease of approximately 3,500 RSF of office space in King of Prussia, PA between Paratek Pharma LLC and Atlantic American Properties Trust
  • Lease of approximately 37,500 RSF of office and lab space in Cambridge, MA between Dicerna Pharmaceuticals, Inc. and King Street Properties
  • Lease of approximately 46,000 RSF of office and lab space in Waltham, MA between NetBio, Inc. and 266 & 275 Second Avenue, LLC
  • Lease of approximately 5,200 RSF of office space in Billerica, MA between Raindance Technologies, Inc. and Fortune Partners, LC

Related Content

Previous Page
Next Page

Interested in working with Brian?

Our team is eager to learn more about your project

This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.